Zobrazeno 1 - 2
of 2
pro vyhledávání: '"B L Claggett"'
Autor:
M Petrie, S Solomon, B L Claggett, K Jering, G Steg, C Granger, E Lewis, L Kober, D Mann, J L Rouleau, J J McMurray, A Maggioni, E Braunwald, M A Pfeffer
Publikováno v:
European Heart Journal. 43
Background/Introduction Sacubitril/valsartan was compared to ramipril in patients with acute myocardial infarction in the PARADISE-MI trial. In the whole trial population sacubitril/valsartan did not reduce the composite primary outcome of CV death o
Autor:
Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.D.S., M.V., B.L.C., M.A.P., A.D.)., Vaduganathan M; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.D.S., M.V., B.L.C., M.A.P., A.D.)., L Claggett B; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.D.S., M.V., B.L.C., M.A.P., A.D.)., Packer M; Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, TX (M.P.).; Imperial College, London, United Kingdom (M.P.)., Zile M; Medical University of South Carolina, Charleston (M.Z.).; Ralph H. Johnson Department of Veterans Affairs Medical Center, Charleston, SC (M.Z.)., Swedberg K; Department of Molecular and Clinical Medicine, University of Gothenburg, Sweden (K.S.).; National Heart and Lung Institute, Imperial College, London, United Kingdom (K.S.)., Rouleau J; Institut de Cardiologie de Montréal, Université de Montréal, Canada (J.R.)., A Pfeffer M; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.D.S., M.V., B.L.C., M.A.P., A.D.)., Desai A; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.D.S., M.V., B.L.C., M.A.P., A.D.)., Lund LH; Department of Medicine, Karolinska Institutet, and Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden (L.H.L.)., Kober L; Department of Cardiology, Heart Centre, Rigshospitalet, Copenhagen University Hospital, Denmark (L.K.)., Anand I; Department of Medicine, VA Medical Center and University of Minnesota, Minneapolis (I.A.)., Sweitzer N; Sarver Heart Center, University of Arizona College of Medicine, Tucson (N.S.)., Linssen G; Department of Cardiology, Hospital Group Twente, Almelo and Hengelo, The Netherlands (G.L.)., Merkely B; Heart and Vascular Center, Semmelweis University, Budapest, Hungary (B.M.)., Luis Arango J; Guatemalan Heart Institute (J.L.A.)., Vinereanu D; University of Medicine and Pharmacy Carol Davila, University and Emergency Hospital of Bucharest, Romania (D.V.)., Chen CH; Department of Medicine, National Yang-Ming University, Taipei, Taiwan, Republic of China (C.-H.C.)., Senni M; Cardiology Division, Cardiovascular Department, Hospital Papa Giovanni XXIII, Bergamo, Italy (M.S.)., Sibulo A; St Luke's Heart Institute, St. Luke's Medical Center, Taguig, Philippines (A.S.)., Boytsov S; National Research Center for Cardiology of the Ministry of Health of the Russian Federation, Moscow (S.B.)., Shi V; Novartis Pharmaceuticals Corporation, East Hanover, NJ (V.S, A.R., M.L.)., Rizkala A; Novartis Pharmaceuticals Corporation, East Hanover, NJ (V.S, A.R., M.L.)., Lefkowitz M; Novartis Pharmaceuticals Corporation, East Hanover, NJ (V.S, A.R., M.L.)., McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, United Kingdom (J.J.V.M.).
Publikováno v:
Circulation [Circulation] 2020 Feb 04; Vol. 141 (5), pp. 352-361. Date of Electronic Publication: 2019 Nov 17.